| Application no. and date | 03707846.6 (espacenet) (Federated) (European Patent Register), 20030211 | | Patent/reg. no. and date | DK/EP 1478358, 20130703 | | Publication date | 20041124 | | Priority no. and date | US 354950 P, 20020211 | | EP pub. no. and date |
EP 1478358 20041124 | | Effective date | | | Applicant/owner | Bayer HealthCare LLC, 100 Bayer Boulevard
Whippany, New Jersey 07981, US | | Applicant ref. no. | P012048EPDK1 EJ/GB | | Inventor | SCOTT, William, J., 210 Saddle Hill Drive
Guilford, CT 06437, US,
ELTING, James, 5 Heatherwood Drive
Madison, CT 06443, US,
HATOUM-MAKDAD, Holia, 43 Joseph Lane
Hamden, CT 06514, US,
DUMAS, Jacques, 98 Farmview Road
Bethany, CT 06524, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 17/06 (2006.01) , A61P 19/02 (2006.01) , A61P 27/02 (2006.01) , A61P 35/00 (2006.01) | | Title | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese | | Int. application no. | US2003004103 | | Int. publication no. | WO2003068228 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
